Purple Biotech (PPBT) Institutional Ownership $3.54 0.00 (0.00%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Purple Biotech (NASDAQ:PPBT)CurrentInstitutional OwnershipPercentage9.64%Number ofInstitutional Buyers(last 12 months)2Number ofInstitutional Sellers(last 12 months)1 Get PPBT Insider Trade Alerts Want to know when executives and insiders are buying or selling Purple Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PPBT Institutional Buying and Selling by Quarter Purple Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024Armistice Capital LLC1,358,000$553K0.0%-35.8%5.381% 2/13/2024Armistice Capital LLC1,882,173$1.47M0.0%N/A8.544% 2/6/2024WuXi AppTec Co. Ltd.194,139$151K0.4%N/A0.881% 1/16/2024Kingswood Wealth Advisors LLC175,100$137K0.0%+34.0%0.795% 8/9/2023Kingswood Wealth Advisors LLC127,950$178K0.1%N/A0.692% 2/3/2023Fisher Asset Management LLC32,200$44K0.0%N/A0.183% 1/28/2022ARK Investment Management LLC662,499$2.58M0.0%-10.0%2.554% 11/15/2021Point72 Asset Management L.P.279,294$1.28M0.0%-46.8%1.077% 10/20/2021Venture Visionary Partners LLC10,068$46K0.0%N/A0.039% 8/16/2021Point72 Asset Management L.P.525,000$2.56M0.0%N/A2.024% 8/16/2021Morgan Stanley37,988$185K0.0%-77.4%0.146% 8/11/2021Condor Capital Management21,000$102K0.0%N/A0.081% 5/18/2021Morgan Stanley167,804$693K0.0%-66.1%0.958% 5/18/2021Orbimed Advisors LLC31,418$130K0.0%-90.9%0.179% 5/13/2021Renaissance Technologies LLC219,035$905K0.0%+69.9%1.251% 3/26/2021Susquehanna International Group LLP20,679$79K0.0%N/A0.132% 2/24/2021Virtu Financial LLC22,988$88K0.0%N/A0.146% 2/16/2021Orbimed Advisors LLC346,197$1.32M0.0%N/A2.202% 2/10/2021Renaissance Technologies LLC128,900$491K0.0%N/A0.820% 2/8/2021Washington Trust Bank16,454$63K0.0%N/A0.105% 11/13/2020Morgan Stanley6,139$27K0.0%+223.4%0.039% (Data available from 1/1/2016 forward) PPBT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PPBT shares? During the previous two years, the following institutional investors and hedge funds held shares of Purple Biotech shares: Armistice Capital LLC ($553K), WuXi AppTec Co. Ltd. ($151K), and Kingswood Wealth Advisors LLC ($137K), Fisher Asset Management LLC ($44K).Learn more on PPBT's institutional investors. What percentage of Purple Biotech stock is owned by institutional investors? 9.64% of Purple Biotech stock is owned by institutional investors. Learn more on PPBT's institutional investor holdings. Which institutional investors have been buying Purple Biotech stock? The following institutional investors have purchased Purple Biotech stock in the last 24 months: Armistice Capital LLC ($1.88M), WuXi AppTec Co. Ltd. ($194.14K), Kingswood Wealth Advisors LLC ($172.40K), and Fisher Asset Management LLC ($32.20K). How much institutional buying is happening at Purple Biotech? Institutional investors have bought a total of 2,280,912 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Which Purple Biotech major shareholders have been selling company stock? The following institutional investors have sold Purple Biotech stock in the last 24 months: Armistice Capital LLC ($757K). How much institutional selling is happening at Purple Biotech? Institutional investors have sold a total of 757,000 shares in the last 24 months. This volume of shares sold represents approximately $0.00 in transactions. Related Companies MIRA Pharmaceuticals Institutional Ownership GeoVax Labs Institutional Ownership Cyclo Therapeutics Institutional Ownership Aprea Therapeutics Institutional Ownership Carisma Therapeutics Institutional Ownership Bullfrog AI Institutional Ownership BioXcel Therapeutics Institutional Ownership Pieris Pharmaceuticals Institutional Ownership Affimed Institutional Ownership MEI Pharma Institutional Ownership This page (NASDAQ:PPBT) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Purple Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PPBT Stock Alerts